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In the U.K. the National Institute of Health and Care Excellence (NICE) is in the processes of updating its 
guidance on the early management of management of non-specific low back pain and sciatica. The draft 
recommendations were released for public consultation on 24 March 2016 and concluded that all forms of 
exercise including stretching, strengthening, aerobic or yoga should be used in the first instance in 
conjunction with encouraging people to continue normal activities of daily living [1]. Physical and 
psychological therapies were also recommended for people who do not improve with previous treatments. 
The draft guidance states “Do not offer TENS [transcutaneous electrical nerve stimulation] for managing 
non-specific low back pain with or without sciatica.” based on a paucity of randomised controlled clinical 
trials (RCTs) on which to judge clinical efficacy. This not only raises doubt about the clinical efficacy of TENS 
for non-specific low back pain but also for the relief of pain for other conditions. Interestingly, in 2016 a 
systematic review of 13 studies (267 patients) evaluating TENS for chronic low back pain found that TENS 
provided a significant reduction in pain for 2 to 24 weeks [2]. The aim of this editorial is to analyse the 
current status of evidence for TENS for pain relief. 
 
TENS is a technique that involves the delivery of mild pulsed electrical currents across the intact surface of 
the skin to stimulate low threshold nerves to relieve pain. A variety of health care practitioners (e.g. 
physicians, nurses, midwives and physiotherapists) offer TENS as a standalone treatment or combined with 
medication for symptomatic relief of inflammatory, neuropathic and musculoskeletal pain. TENS is popular 
with patients and practitioners because it is inexpensive, available without prescription, easy to self-
administer and safe, with limited potential for toxicity or overdose [3]. One should be vigilant to claims by 
manufacturers that advanced technology incorporated into device design enables specific interactions with 
physiological mechanisms because any relationship between specific characteristics of electrical stimulation 
and physiological mechanisms may not influence clinically outcomes to any meaningful effect. Psychosocial 
factors have a strong influence on pain response. Thus, prescriptive, over-complicated TENS technique 
should be avoided. For most patients administering TENS to produce a strong non painful TENS sensation at 
the site of pain (conventional TENS) is effective. 
 
Uncertainty about the usefulness of TENS has persisted since it was introduced into mainstream medicine 
in the early 1970s. Since then published research on the mechanisms of action, factors influencing response 
and clinical efficacy and effectiveness have risen exponentially. Randomised placebo-controlled clinical 
trials are used to assess clinical efficacy and for TENS will answer the question: Do you need to put batteries 
in the TENS device to get beneficial effects? A free text search in PubMed (01 July 2016) using the term 
‘transcutaneous electrical nerve stimulation’ AND ‘pain’ found 682 hits for RCT, 195 hits for systematic 
review and 49 hits for meta-analysis. The majority of systematic reviews on TENS find inconclusive or 
conflicting evidence for clinical efficacy due to insufficient good quality research. However, subgroup 
  
analyses suggest that TENS is superior to placebo when administered using strong non painful stimulation 
within or close to site of pain (i.e. appropriate TENS technique) [4, 5].  
 
The first systematic reviews on TENS were published in 1990s and challenged the belief that TENS was 
efficacious for acute pain [6, 7]. The first meta-analysis on TENS was conducted in 2003 and found that 
TENS reduced post-operative consumption of analgesic medication to a greater extent than placebo when 
TENS was administered using appropriate technique [5]. More recent systematic reviews confirm the 
efficacy of TENS for post-thoracotomy and post-sternotomy pain [8, 9]. The most recent Cochrane review 
on TENS on acute pain in adults included 19 RCTs (1346 participants) of procedural (cervical laser 
treatment, venepuncture, screening flexible sigmoidoscopy) and non-procedural pain (postpartum uterine 
contractions and rib fractures) [10]. A meta-analysis of six RCTs found that TENS reduced pain intensity by 
31.79mm to 17.46mm (95% confidence intervals) on a 100 mm visual analogue scale compared with 
placebo. The likelihood of achieving ≥ 50% reduction in pain was 2.42 to 6.32 in favour of TENS over 
placebo (95% confidence intervals for relative risk, four RCTs). However, there was a high risk of bias due to 
inadequate sample sizes and unsuccessful blinding of treatment interventions so reviewers concluded that 
evidence was only tentative. Evidence to support the use of TENS for pain during childbirth is also tentative 
due to conflicting findings, although women receiving TENS are more ‘satisfied’ than those receiving 
placebo [11]. There is insufficient evidence for dysmenorrhoea, angina pectoris-like chest pain, and pain 
from lacerations, fractures, haematomas, contusions and dental procedures and that that exists is 
conflicting.  
 
The largest meta-analysis on TENS was conducted a decade ago and provides evidence that TENS provides 
three times more relief of pain than placebo for chronic musculoskeletal conditions [12]. The analysis 
included 29 RCTs with 335 participants receiving placebo, 474 participants receiving TENS or percutaneous 
electrical nerve stimulation, and 418 participants crossed over to receive both active placebo electrical 
nerve stimulation. There were 32 comparisons on TENS. The review methodology was criticized for 
combining multiple diseases at the expense of homogeneity. To date, there are Cochrane and non-
Cochrane systematic reviews on TENS for chronic pain, cancer pain, knee osteoarthritis, rheumatoid 
arthritis, neck pain, low back pain, chronic and recurrent headache, neuropathic pain, post-amputation 
pain, post-stroke pain, diabetic peripheral neuropathy, spinal cord injury, and central pain associated with 
multiple sclerosis. The majority of these reviews conclude that meaningful judgements on the clinical 
efficacy of TENS is not possible because RCTs were of insufficient quantity or had a high risk of bias 
associated with methodology. This concern is not unique to TENS as a review of 34 treatments (76 RCTs) for 




There are more systematic reviews than RCTs evaluating TENS for some chronic pain conditions. For 
conditions where sufficient RCTs exist there is concern about trial fidelity with inadequate TENS technique 
and dosage common in RCTs [14]. The contradictory nature of evidence provided by TENS research has 
caused apparent inconsistencies in professional and regulatory body recommendations creating 
uncertainty for practitioners.  For example, it is recommended in NICE guidelines that TENS should be 
offered for short-term relief of osteoarthritis [15], rheumatoid arthritis [16] and musculoskeletal pain 
secondary to multiple sclerosis [17], but not for non-specific low back pain [18]. Practitioners should be 
mindful that recommendations not to offer TENS are based on a paucity of evidence on which to make a 
judgement rather than evidence of inferiority or equivalence to placebo.  
 
TENS should be considered a complex intervention influenced by a variety of factors, including the choice of 
TENS settings and pattern of TENS usage. The possible combinations of electrical output characteristics 
even on the simplest of TENS devices is vast, and the search for “optimal stimulator settings” has created a 
body of research literature that is impossible to interpret. This has fuelled myths about how best to use 
TENS in clinical practice. Research from studies using pain free participants exposed to experimentally 
induced pain suggest that favourable responses are obtained when the intensity of TENS is strong but not 
painful and administered at the site of pain (often termed “conventional TENS”). Thus, practitioners need 
to educate individuals about safe and appropriate TENS technique, including the need for patients to 
regularly self-administer TENS. Some patients stop using TENS because they find that the amount of effort 
needed to administer treatment is disproportionate to the amount of pain relief achieved. Recently, 
Gladwell et al. [19] conducted semi-structured interviews with 9 patients to explore their experiences of 
using TENS to manage chronic musculoskeletal pain. Challenges to optimize the use of TENS included 
frequently having to adjust electrode position and TENS settings to maintain pain relief. This research 
demonstrated the need to incorporate a learning phase to allow patients to optimize TENS usage. TENS 
success is optimised when new TENS users have realistic expectations from treatment and are provided 
with strategies to enable them to sustain motivation to self-administer treatment and troubleshoot 
declining response. A framework to support this approach is available in the book “Transcutaneous 
electrical nerve stimulation (TENS). Research to support clinical practice” [20]. 
 
Trying to interpret research on TENS is at best challenging and at worst futile because synthesising research 
findings is hindered by inconsistent terminology, variability in clinical technique, poor study design. Current 
research evidence suggests that it is reasonable to offer TENS as an adjunct to core treatment for most 
painful conditions, especially because it is inexpensive and has a favourable safety profile compared with 
long-term medication. Whether costs associated with TENS devices and accessories is covered by 
healthcare providers or patients is a matter for policymakers but practitioners need to be able to advise 
and educate patient about TENS because patients may purchase TENS without prescription. Investigators 
  
may consider the use of an enriched enrolment, randomized withdrawal design using a two-stage 
recruitment process in future RCTs. 
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